Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
MORINIDAZOLE
1- [3- (4-morpholinyl) -2-hydroxypropyl] -2-methyl-5- nitro -1H- imidazole
CAS 92478-27-8
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Morinidazole was approved by China Food and Drug Administration (CFDA) on February 24, 2014. It was developed and marketed as a step Lingda ® by Hansoh Pharmaceutical.
Morinidazole is a nitroimidazoles antibiotic indicated for the treatment of bacterial infections including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria.
Image may be NSFW.
Clik here to view.
PATENT
WO2006058457A1.
http://www.google.com/patents/WO2006058457A1?cl=en
……………………….
PATENT
CN1981764A.
https://www.google.com/patents/CN1981764A?cl=en
1- (2,3-epoxypropoxy yl) -2-methyl-5-nitro-imidazole (10g), morpholino (10g), 100ml of acetonitrile under reflux for 2 hours, vacuum recovery of acetonitrile, water was added 100ml, heating to the whole solution, filtered hot, let cool, filtering, washing and drying to obtain an off-white solid (11g).
Proton nuclear magnetic resonance data: 1HNMR (CD3Cl) δ2.39 ~ 2.73 (6H, m) δ2.61 (3H, s) δ3.71 ~ 3.81 (4H, m) δ4.10 ~ 4.17 (2H, m) δ4 .63 ~ 4.66 (1H, m) δ8.00 (1H, s)
CN 102199147
http://www.google.com/patents/CN102199147A?cl=en
CN 1605586
https://www.google.com/patents/CN1605586A?cl=en
Example 7 Preparation of α- (morpholino-1-yl) methyl-2-methyl-5-nitroimidazole-1-ethanol according to Example 4 the same manner as in Preparation α- (morpholino-1-yl) methyl-2-methyl-5-nitroimidazole-1-ethanol, except for using morpholine instead of 4-hydroxypiperidine, prepared by the present invention Compound 7. Proton nuclear magnetic resonance data: 1HNMR (CD3Cl) δ2.39 ~ 2.73 (6H, m) δ2.61 (3H, s) δ3.71 ~ 3.81 (4H, m) δ4.10 ~ 4.17 (2H, m) δ4
Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
NMR PREDICT
Image may be NSFW.
Clik here to view.
1H NMR PREDICT
Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
13C NMR PREDICT
Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
COSY
Image may be NSFW.
Clik here to view.
| CN1810815B | Mar 8, 2006 | Mar 16, 2011 | 陕西合成药业有限公司 | Nitroimidazole derivative for treatment |
| CN1903846B | Aug 15, 2006 | Jul 13, 2011 | 杨成 | Ornidazole derivative used for therapy, its preparation method and use |
| CN100387233C | Jun 9, 2006 | May 14, 2008 | 南京圣和药业有限公司 | Use of levo morpholine nidazole for preparing medicine for antiparasitic infection |
| CN100427094C | Dec 13, 2005 | Oct 22, 2008 | 江苏豪森药业股份有限公司 | Usage of alpha-(Morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines |
| CN100540549C | Dec 15, 2005 | Sep 16, 2009 | 南京圣和药业有限公司 | Alpha-substituted-2-methyl-5-nitro-diazole-1-alcohol derivative with optical activity |
| WO2007079653A1 * | Dec 25, 2006 | Jul 19, 2007 | Junda Cen | OPTICALLY PURE α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOLE-1-ETHANOL DERIVATIVES |
Image may be NSFW.
Clik here to view.
Filed under: cfda, china pipeline, Uncategorized Tagged: China Food and Drug Administration, Jiangsu Hansoh Pharmaceutical, MORINIDAZOLE, pelvic inflammatory disease Image may be NSFW.
Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
